Prima BioMed Company Profile (NASDAQ:PBMD)

About Prima BioMed

Prima BioMed logoPrima BioMed Limited is an Australia-based biotechnology company. The Company is engaged in research, development and commercialization of licensed medical biotechnology. The Company focuses on cancer immunotherapy research. The Company's main pipeline of products is based on the LAG-3 immune control mechanism, which plays a role in the regulation of the T cell immune response. The Company's product is a T cell immunostimulatory factor (APC activator), IMP321, for cancer chemoimmunotherapy, which has completed Phase II trials. In addition, it has developed infrastructure for a cell-based therapy manufacturing platform and taken CVac, an autologous dendritic cell-based product through Phase II clinical trials for ovarian cancer patients in remission. The Company's other products include IMP731 for autoimmune disease, and IMP701 for cancer and chronic infectious disease.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: PBMD
  • CUSIP:
Key Metrics:
  • Previous Close: $0.89
  • 50 Day Moving Average: $0.873
  • 200 Day Moving Average: $0.951
  • 52-Week Range: $68,721,000.00 - $0.72
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -2.46
  • P/E Growth: 0.000
  • Market Cap: $60.82M
  • Outstanding Shares: 68,721,000
  • Beta: 1.9
Debt:
  • Debt-to-Equity Ratio: 0.14%
  • Current Ratio: 14.75%
Additional Links:
Companies Related to Prima BioMed:

Analyst Ratings

Consensus Ratings for Prima BioMed (NASDAQ:PBMD) (?)
Ratings Breakdown: 4 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $5.00 (464.97% upside)

Analysts' Ratings History for Prima BioMed (NASDAQ:PBMD)
Show:
DateFirmActionRatingPrice TargetDetails
9/8/2016FBR & CoSet Price TargetBuy$6.00View Rating Details
8/26/2016Roth CapitalReiterated RatingBuy$6.00View Rating Details
7/12/2016Maxim GroupReiterated RatingBuy$5.00View Rating Details
6/22/2016HC WainwrightReiterated RatingBuyView Rating Details
(Data available from 9/25/2014 forward)

Earnings

Earnings History for Prima BioMed (NASDAQ:PBMD)
No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for Prima BioMed (NASDAQ:PBMD)
Current Year EPS Consensus Estimate: $-0.080 EPS
Next Year EPS Consensus Estimate: $-0.360 EPS

Dividends

Dividend History for Prima BioMed (NASDAQ:PBMD)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Prima BioMed (NASDAQ:PBMD)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Latest Headlines for Prima BioMed (NASDAQ:PBMD)
DateHeadline
investornewswire.com logoShares Of Prima BioMed Ltd (NASDAQ:PBMD) Expected To Hit $6 - Investor Newswire (NASDAQ:PBMD)
www.investornewswire.com - September 21 at 6:18 PM
News IconStock Update on Earnings & Estimates for Prima BioMed Ltd (NASDAQ:PBMD) - Frisco Fastball (NASDAQ:PBMD)
friscofastball.com - September 17 at 11:04 AM
capitalcube.com logoPrima BioMed Ltd. :PBMD-US: Earnings Analysis: 2016 By the Numbers : September 13, 2016 (NASDAQ:PBMD)
www.capitalcube.com - September 13 at 11:33 AM
News IconShares Gapping Higher Pre-Market: Prima Biomed Ltd. (NASDAQ:PBMD) - Post News (NASDAQ:PBMD)
www.kentuckypostnews.com - August 25 at 6:47 PM
investornewswire.com logoPrima BioMed Ltd (NASDAQ:PBMD) Gets 0 Recommendations To Sell - Investor Newswire (NASDAQ:PBMD)
www.investornewswire.com - August 25 at 6:47 PM
streetinsider.com logoPrima BioMed (PBMD) Announces European Patent for IMP731 Antibody - StreetInsider.com (NASDAQ:PBMD)
www.streetinsider.com - August 25 at 6:47 PM
4-traders.com logoPrima BioMed : European Patent Grants for IMP731 Antibody (NASDAQ:PBMD)
www.4-traders.com - August 25 at 11:50 AM
streetinsider.com logoPrima BioMed (PBMD) Announces European Patent for IMP731 Antibody (NASDAQ:PBMD)
www.streetinsider.com - August 25 at 11:50 AM
publicnow.com logoEuropean Patent grants for IMP731 Antibody (NASDAQ:PBMD)
www.publicnow.com - August 25 at 11:50 AM
investornewswire.com logoWill Prima BioMed Ltd (NASDAQ:PBMD) Hit $6 Price Target? - Investor Newswire (NASDAQ:PBMD)
www.investornewswire.com - August 19 at 9:45 AM
4-traders.com logoPrima BioMed : Operational Update (NASDAQ:PBMD)
www.4-traders.com - August 18 at 9:48 AM
News IconPrima BioMed Ltd: Operational Update (NASDAQ:PBMD)
www.andhranews.net - August 18 at 9:48 AM
streetinsider.com logoPrima BioMed (PBMD) Receives Nasdaq Listing Notification (NASDAQ:PBMD)
www.streetinsider.com - August 11 at 9:59 AM
streetinsider.com logoPrima BioMed (PBMD) Receives Nasdaq Listing Notification - StreetInsider.com (NASDAQ:PBMD)
www.streetinsider.com - August 10 at 9:50 AM
publicnow.com logoPrima BioMed receives NASDAQ Notice of Bid Price Deficiency (NASDAQ:PBMD)
www.publicnow.com - August 10 at 9:50 AM
tradecalls.org logoPrima BioMed Ltd (PBMD) Shares are Down -4.85% - Trade Calls (NASDAQ:PBMD)
www.tradecalls.org - August 9 at 6:59 PM
ftsenews.co.uk logoBrokers Issue Average Price Target Of 5.00 On Prima BioMed Ltd (PBMD) - FTSE News (NASDAQ:PBMD)
www.ftsenews.co.uk - August 3 at 7:05 PM
investing.com logoPrima BioMed Makes Progress For Breast Cancer Research (NASDAQ:PBMD)
www.investing.com - July 27 at 7:07 PM
fiscalstandard.com logoBrokers Issue Average Price Target Of 5.00 On Prima BioMed Ltd (PBMD) - Fiscal Standard (NASDAQ:PBMD)
www.fiscalstandard.com - July 21 at 7:03 PM
investornewswire.com logoIs $6 Price Target Attainable For Prima BioMed Ltd (NASDAQ:PBMD)? - Investor Newswire (NASDAQ:PBMD)
www.investornewswire.com - July 21 at 9:38 AM
ftsenews.co.uk logoNew Broker Ratings For Prima BioMed Ltd (PBMD) - FTSE News (NASDAQ:PBMD)
www.ftsenews.co.uk - July 19 at 7:26 AM
News IconPrima Biomed Limited Ads (NASDAQ:PBMD) Sellers Covered 2.81% of Their Shorts - Consumer Eagle (NASDAQ:PBMD)
www.consumereagle.com - July 18 at 12:11 PM
News IconHC Stocks Reports: Horizon Pharma PLC (NASDAQ:HZNP), Prima BioMed Ltd (ADR) (NASDAQ:PBMD) - share market updates (press release) (NASDAQ:PBMD)
sharemarketupdates.com - July 14 at 10:20 AM
investornewswire.com logoStrong Sell Calls For Prima BioMed Ltd (NASDAQ:PBMD) At 0 - Investor Newswire (NASDAQ:PBMD)
www.investornewswire.com - July 13 at 7:05 PM
publicnow.com logoPrima BioMed collaborates in Investigator Sponsored New Clinical Trial for IMP321 in Solid Tumors (NASDAQ:PBMD)
www.publicnow.com - July 12 at 3:43 AM
News IconHC Stocks Outlines: UnitedHealth Group Inc (NYSE:UNH), Prima BioMed Ltd (ADR) (NASDAQ:PBMD) - share market updates (press release) (NASDAQ:PBMD)
sharemarketupdates.com - July 11 at 11:25 AM
News IconPrima Biomed Limited Ads (NASDAQ:PBMD) Shorts Decreased by 2.81% After Short Covering - Engelwood Daily (NASDAQ:PBMD)
www.engelwooddaily.com - July 7 at 9:36 AM
investornewswire.com logoPrima BioMed Ltd (NASDAQ:PBMD) Expected to Reach Highs Of $6 - Investor Newswire (NASDAQ:PBMD)
www.investornewswire.com - July 6 at 6:55 PM
fiscalstandard.com logoPrima BioMed Ltd (PBMD) Current Analyst Ratings - Fiscal Standard (NASDAQ:PBMD)
www.fiscalstandard.com - July 2 at 6:22 PM
investornewswire.com logoStrong Sell Calls Recommendations For Prima BioMed Ltd (NASDAQ:PBMD) At 0 - Investor Newswire (NASDAQ:PBMD)
www.investornewswire.com - June 29 at 6:41 PM
kcregister.com logoTop Wall Street Stories: Viavi Solutions Inc. (NASDAQ:VIAV), Prima Biomed Ltd. (NASDAQ:PBMD), Lifetime Brands ... - KC Register (NASDAQ:PBMD)
www.kcregister.com - June 28 at 11:34 AM
News IconPrima Biomed Limited Ads (NASDAQ:PBMD) Shorts Decreased by 2.81% After Short Covering - Press Telegraph (NASDAQ:PBMD)
presstelegraph.com - June 28 at 11:34 AM
fiscalstandard.com logoNext Weeks Broker Price Targets For Prima BioMed Ltd (PBMD) - Fiscal Standard (NASDAQ:PBMD)
www.fiscalstandard.com - June 27 at 10:53 AM
investornewswire.com logoStrong Buy Calls Count For Prima BioMed Ltd (NASDAQ:PBMD) At 4 - Investor Newswire (NASDAQ:PBMD)
www.investornewswire.com - June 22 at 6:40 PM
streetinsider.com logoPrima BioMed (PBMD) Says IMP321 Combo Safe, Well Tolerated at 5mg Level in Breast Cancer - StreetInsider.com (NASDAQ:PBMD)
www.streetinsider.com - June 22 at 6:40 PM
finance.yahoo.com logoPrima Reports Favorable Initial Breast Cancer Study Data (NASDAQ:PBMD)
finance.yahoo.com - June 22 at 3:30 PM
rttnews.com logoKeep An Eye On Nicox, OPK Gets FDA Nod, PBMD Abuzz, RDHL On The Move (NASDAQ:PBMD)
www.rttnews.com - June 22 at 11:26 AM
finance.yahoo.com logoPrima BioMed Announces First Safety, Pharmacokinetics and Immuno-Monitoring Data From Phase IIb Clinical Trial of IMP321 (NASDAQ:PBMD)
finance.yahoo.com - June 22 at 11:26 AM
streetinsider.com logoPrima BioMed (PBMD) Says IMP321 Combo Safe, Well Tolerated at 5mg Level in Breast Cancer (NASDAQ:PBMD)
www.streetinsider.com - June 22 at 11:26 AM
finance.yahoo.com logo3:18 am Prima Biomed presents initial safety data from Phase IIb Clinical Trial of IMP321 (NASDAQ:PBMD)
finance.yahoo.com - June 22 at 3:18 AM
kcregister.com logoPrima Biomed Ltd. (NASDAQ:PBMD) Went Up 2.94%: Navidea Biopharmaceuticals, Inc (NYSEMKT:NAVB), Rockwell ... - KC Register (NASDAQ:PBMD)
www.kcregister.com - June 21 at 11:07 AM
investornewswire.com logoTrend Of Rating Given To Prima BioMed Ltd (NASDAQ:PBMD) - Investor Newswire (NASDAQ:PBMD)
www.investornewswire.com - June 15 at 6:43 PM
streetinsider.com logoPrima BioMed (PBMD) Regains Nasdaq Listing Compliance - StreetInsider.com (NASDAQ:PBMD)
www.streetinsider.com - June 7 at 9:29 AM
publicnow.com logoPrima BioMed to Maintain NASDAQ Listing (NASDAQ:PBMD)
www.publicnow.com - June 7 at 3:08 AM
News IconPrima BioMed Ltd (PBMD) Do Brokers Advise Buy, Sell Or Hold? - Share Trading News (NASDAQ:PBMD)
www.sharetrading.news - June 2 at 9:43 AM
isstories.com logoSizzling Healthcare Stocks to Focus: Prima BioMed Ltd (NASDAQ:PBMD) , PAREXEL International Corporation ... - Is stories (NASDAQ:PBMD)
www.isstories.com - May 16 at 11:44 AM
News IconAdvantage: Australia. Biotechs Down Under Surge Ahead in Regenerative Medicine and Immuno-Oncology (NASDAQ:PBMD)
www.investorideas.com - May 13 at 11:33 AM
streetinsider.com logoPrima BioMed (PBMD), Sydys Enter Into Sale and Licensing Agreement (NASDAQ:PBMD)
www.streetinsider.com - May 13 at 11:33 AM
benzinga.com logoHere's Why Prima BioMed Is Up 15% - Benzinga (NASDAQ:PBMD)
www.benzinga.com - May 12 at 11:28 AM
finance.yahoo.com logoUS Patent Grants for IMP731 Antibody (NASDAQ:PBMD)
finance.yahoo.com - January 27 at 6:00 PM

Social

Prima BioMed (NASDAQ:PBMD) Chart for Sunday, September, 25, 2016


Last Updated on 9/25/2016 by MarketBeat.com Staff